Big Pharma unites to help boost renewable energy for supply chains in China and India
The Sustainable Markets Initiative (SMI) Health Systems Task Force — a collective of biopharma and global health companies — announced Wednesday that it is in “advanced discussions” with China and India-based energy providers for them to bolster renewable energy access for supply chains.
This collaboration is the first time biopharma companies have worked together on such an initiative in China and India, which make up 50% of the materials for medicines, according to a press release. The initiative, which was revealed before COP28 starts on Thursday in Dubai, is a move toward global net zero health systems.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.